Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2015, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2015-07-30
DOI
10.1155/2015/191382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence
- (2015) Rafael Simó et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy
- (2014) Rafael Simó et al. DIABETES CARE
- Interleukins as markers of inflammation in malignant and benign thyroid disease
- (2014) Xeni Provatopoulou et al. INFLAMMATION RESEARCH
- Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
- (2014) S. Matthijs Boekholdt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fenofibrate: A New Treatment for Diabetic Retinopathy. Molecular Mechanisms and Future Perspectives
- (2013) Rafael Simo et al. CURRENT MEDICINAL CHEMISTRY
- The Relationship Between Diabetic Retinopathy and Cognitive Impairment
- (2013) R. R. Crosby-Nwaobi et al. DIABETES CARE
- VEGF Levels in Plasma in Relation to Platelet Activation, Glycemic Control, and Microvascular Complications in Type 1 Diabetes
- (2013) R. O. Schlingemann et al. DIABETES CARE
- Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
- (2013) Lloyd Paul Aiello et al. DIABETES CARE
- Association between serum adipocytokine levels and microangiopathies in patients with type 2 diabetes mellitus
- (2013) Chan-Hee Jung et al. Journal of Diabetes Investigation
- Fenofibrate – A Potential Systemic Treatment for Diabetic Retinopathy?
- (2012) Tien Yin Wong et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes
- (2012) Andina Hu et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Diabetic Retinopathy
- (2012) David A. Antonetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids
- (2011) M. B. Sasongko et al. DIABETES CARE
- ASSOCIATION OF TUMOR NECROSIS FACTOR α, INTERLEUKIN 6, AND INTERLEUKIN 10 PROMOTER POLYMORPHISM WITH PROLIFERATIVE DIABETIC RETINOPATHY IN TYPE 2 DIABETIC SUBJECTS
- (2011) Suman K. Paine et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TNF- Signals Through PKC /NF- B to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability
- (2010) C. A. Aveleira et al. DIABETES
- Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases
- (2009) Takeru Yoshimura et al. PLoS One
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
- (2008) Anne Katrin Sjølie et al. LANCET
- Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
- (2008) Matthew J McQueen et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now